Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
<p>In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.</p>
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Onkogematologiâ |
| Subjects: | |
| Online Access: | http://oncohematology.abvpress.ru/index.php/ongm/article/view/95 |
| id |
doaj-4893c4a74e15490f88df76726c28246f |
|---|---|
| record_format |
Article |
| spelling |
doaj-4893c4a74e15490f88df76726c28246f2020-11-25T00:12:09ZrusABV-pressOnkogematologiâ1818-83462014-07-016247110Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabineE. V. Kataeva0A. K. Golenkov1E. V. Trifonova2G. A. Dudina3T. A. Mitina4L. L. Vysotskaya5T. D. Lutskaya6I. V. Buravtsova7R. V. Gorenkov8Yu. Yu. Chuksina9V. V. Yazdovskiy10M.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical Institute<p>In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.</p>http://oncohematology.abvpress.ru/index.php/ongm/article/view/95chronic lymphocytic leukemiaresistant patientsalemtuzumabfludarabine |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
E. V. Kataeva A. K. Golenkov E. V. Trifonova G. A. Dudina T. A. Mitina L. L. Vysotskaya T. D. Lutskaya I. V. Buravtsova R. V. Gorenkov Yu. Yu. Chuksina V. V. Yazdovskiy |
| spellingShingle |
E. V. Kataeva A. K. Golenkov E. V. Trifonova G. A. Dudina T. A. Mitina L. L. Vysotskaya T. D. Lutskaya I. V. Buravtsova R. V. Gorenkov Yu. Yu. Chuksina V. V. Yazdovskiy Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine Onkogematologiâ chronic lymphocytic leukemia resistant patients alemtuzumab fludarabine |
| author_facet |
E. V. Kataeva A. K. Golenkov E. V. Trifonova G. A. Dudina T. A. Mitina L. L. Vysotskaya T. D. Lutskaya I. V. Buravtsova R. V. Gorenkov Yu. Yu. Chuksina V. V. Yazdovskiy |
| author_sort |
E. V. Kataeva |
| title |
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
| title_short |
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
| title_full |
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
| title_fullStr |
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
| title_full_unstemmed |
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
| title_sort |
treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
| publisher |
ABV-press |
| series |
Onkogematologiâ |
| issn |
1818-8346 |
| publishDate |
2014-07-01 |
| description |
<p>In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.</p> |
| topic |
chronic lymphocytic leukemia resistant patients alemtuzumab fludarabine |
| url |
http://oncohematology.abvpress.ru/index.php/ongm/article/view/95 |
| work_keys_str_mv |
AT evkataeva treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT akgolenkov treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT evtrifonova treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT gadudina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT tamitina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT llvysotskaya treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT tdlutskaya treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT ivburavtsova treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT rvgorenkov treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT yuyuchuksina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT vvyazdovskiy treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine |
| _version_ |
1725401006892646400 |